SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-19-007762
Filing Date
2019-02-14
Accepted
2019-02-14 11:21:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D tv513501_sc13d.htm SC 13D 45982
  Complete submission text file 0001144204-19-007762.txt   47520
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Subject) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-58217 | Film No.: 19602812
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2925 RICHMOND AVENUE SUITE 1274 HOUSTON TX 77098
Business Address
Vera Juan (Filed by) CIK: 0001755495 (see all company filings)

Type: SC 13D